We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+5.09%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$168M
AUM Growth
+$5.28M
Cap. Flow
-$1.1M
Cap. Flow %
-0.65%
Top 10 Hldgs %
28.41%
Holding
314
New
29
Increased
45
Reduced
71
Closed
9

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.64M
2
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$788K
3
UEIC icon
Universal Electronics
UEIC
+$598K
4
ASRT
Assertio
ASRT
+$584K
5
TAL icon
TAL Education Group
TAL
+$557K

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$3.81M
2
EGY icon
Vaalco Energy
EGY
+$945K
3
ENSG icon
The Ensign Group
ENSG
+$787K
4
PVH icon
PVH
PVH
+$693K
5
CYNO
Cynosure, Inc. Class A
CYNO
+$674K

Sector Composition

Rank Sector Weight
1 Technology 16.79%
2 Healthcare 16.33%
3 Industrials 9.84%
4 Consumer Discretionary 8.38%
5 Financials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IFGL icon
101
iShares International Developed Real Estate ETF
IFGL
$83.1M
$200K 0.12%
6,210
-400
-6% -$12.6K
IXP icon
102
iShares Global Comm Services ETF
IXP
$529M
$183K 0.11%
2,055
-150
-7% -$10.2K
DBU
103
DELISTED
WISDOMTREE GLOBAL EX-US UTILITY FND (DE)
DBU
$172K 0.1%
8,450
– –
XOM icon
104
ExxonMobil
XOM
$644B
$171K 0.1%
1,700
– –
DUK icon
105
Duke Energy
DUK
$97.8B
$161K 0.1%
2,172
+100
+5% +$7.19K
GOOG icon
106
Alphabet (Google) Class C
GOOG
$4.36T
$158K 0.09%
5,475
+1,299
+31% +$35.2K
IBB icon
107
iShares Biotechnology ETF
IBB
$9.34B
$158K 0.09%
1,845
+390
+27% +$30.7K
PM icon
108
Philip Morris
PM
$297B
$156K 0.09%
1,850
– –
BHP icon
109
BHP
BHP
$215B
$154K 0.09%
2,661
-177
-6% -$10.4K
AGG icon
110
iShares Core US Aggregate Bond ETF
AGG
$137B
$147K 0.09%
1,345
– –
JPXN
111
iShares JPX-Nikkei 400 ETF
JPXN
$134M
$143K 0.09%
1,274
-212
-14% -$10.4K
FCX icon
112
Freeport-McMoran
FCX
$90B
$140K 0.08%
3,835
-200
-5% -$6.85K
T icon
113
AT&T
T
$159B
$139K 0.08%
5,193
– –
EWA icon
114
iShares MSCI Australia ETF
EWA
$1.39B
$138K 0.08%
5,300
-400
-7% -$10.6K
IVV icon
115
iShares Core S&P 500 ETF
IVV
$878B
$138K 0.08%
700
-24
-3% -$4.59K
LO
116
DELISTED
LORILLARD INC COM STK
LO
$137K 0.08%
2,250
– –
VCR icon
117
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$134K 0.08%
1,230
-190
-13% -$20.1K
CAT icon
118
Caterpillar
CAT
$375B
$124K 0.07%
1,141
– –
PEP icon
119
PepsiCo
PEP
$190B
$123K 0.07%
1,375
-100
-7% -$8.63K
MO icon
120
Altria Group
MO
$114B
$122K 0.07%
2,900
– –
QQQ icon
121
Invesco QQQ Trust
QQQ
$453B
$115K 0.07%
+1,225
New +$109K
BSV icon
122
Vanguard Short-Term Bond ETF
BSV
$44.7B
$112K 0.07%
1,400
– –
IEZ icon
123
iShares US Oil Equipment & Services ETF
IEZ
$361M
$109K 0.07%
1,400
-250
-15% -$17.8K
INTC icon
124
Intel
INTC
$455B
$107K 0.06%
3,470
– –
OHI icon
125
Omega Healthcare
OHI
$15.1B
$107K 0.06%
+2,900
New +$103K
3 4
5
6 7

Similar funds

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
MWS
Maxwell Wealth Strategies Pleasanton, California $245M AUM 23.39% 1-Year Est. Return
LHR
Lunate Holding RSC Al Maryah Island, Abu Dhabi, United Arab Emirates $211M AUM
HPFG
Hart & Patterson Financial Group Amherst, Massachusetts $206M AUM 7.82% 1-Year Est. Return
GWM
Gray Wealth Management Bangor, Maine $264M AUM 19.5% 1-Year Est. Return
KC
Kades & Cheifetz Berwyn, Pennsylvania $195M AUM 11.87% 1-Year Est. Return
SL
SIB LLC New York, New York $190M AUM 9.27% 1-Year Est. Return
CSWM
Cassady Schiller Wealth Management Cincinnati, Ohio $273M AUM 17.91% 1-Year Est. Return

AlphaMark Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, AlphaMark Advisors held 314 positions worth $168M, up 3.3% from $162M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

AlphaMark Advisors's Q2 2014 filing shows 29 new, 45 increased, 71 reduced and 9 closed positions. Its largest new stake was Gilead Sciences: 46,823 shares worth $3.88M. The largest sale was Perrigo, an estimated $3.81M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • AlphaMark Advisors's largest Q2 2014 buy was Gilead Sciences: 46,823 shares worth $3.88M.
  • AlphaMark Advisors added most to Momenta Pharmaceuticals, Inc. in Q2 2014, an estimated $788K increase.
  • AlphaMark Advisors's biggest Q2 2014 reduction was Perrigo, cutting an estimated $3.81M.
  • AlphaMark Advisors fully exited Vaalco Energy in Q2 2014, selling an estimated $945K.
  • AlphaMark Advisors's ten largest holdings make up 28% of its $168M portfolio in Q2 2014.
  • AlphaMark Advisors opened 29 new positions and closed 9 in Q2 2014.
  • AlphaMark Advisors's portfolio value rose 3.3% quarter-over-quarter to $168M.

Based on AlphaMark Advisors's 13F filing for Q2 2014, filed 29 Jul 2014.